HCFA expands investigation into Gambro's billing practices
This article was originally published in Clinica
Executive Summary
The US government agency investigating the billing operations of Gambro's US laboratory testing is to extend the time-period under examination. The investigations into the Gambro subsidiaries, Gambro Healthcare Laboratory Services and Dialysis Holdings Laboratory Services, will now cover billing activities throughout 1994 and 1995 as well as the original two periods between 1996 and 1998.
You may also be interested in...
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.